StockMarketLoopMaking Easy MoneySubscribe
Analysis$ACRS

Somebody Is Still Shorting $ACRS. The Data Says They May Regret It

A crowded short against a stock that refuses to fall is a position with a deadline. My read on how it ends.

Somebody Is Still Shorting $ACRS. The Data Says They May Regret It

Listen: hear this article read aloud (about 2 min).

Aclaris Therapeutics keeps going up and the short keeps pressing. One of those has to give.

$ACRS sits at $3.60, $0.80 below its 20-day high of $4.40 and $0.33 above its 20-day low of $3.28.

My read: lean bullish. Buyers are close enough to force the issue, but I want volume before I call it a breakout.

A short that will not fall

Against its own 60-session range, $ACRS is 45.4% below the high of $6.60 (Aug 25) and 13.3% above the low of $3.18 (Oct 8). $ACRS closed higher in 3 of its last 9 sessions.

Volume over the last five sessions averaged 0.9x the twenty sessions before them.

The largest one-day move in the past twenty sessions was +8.7% on Nov 9. 64% of ACRS's off-exchange volume printed as short sales (FINRA daily short volume), against a normal 54%. Days to cover: 4.0.

What I make of it: a crowded short matters only if the stock stops falling, and then covering becomes buying. Whether that starts here is the whole question.

What is already in the price

Off-exchange trading: NORMAL: $875K block at $3.50, -46% yesterday's biggest. Biggest single off-exchange print: 250,000 shares at $3.50, about $875K, on an uptick (buyer lifted). A print that size is one order being crossed away from the public book, not a crowd of small trades.

In options, dealers long gamma, call wall $4.00, put wall $3.00, gamma flip near $2.00, hedge pressure 0% of an average day's volume. Days to cover 4.0, 11.6M shares short, short interest -23.0% since the last report. Squeeze risk 24 of 100; shorts pressing 71 of 100.

Across the broader market, the read is Lean bearish (bias -25).

Insiders: quiet.

What I make of it: the data agrees with itself more than it argues, and that counts for something. It still falls short of proof.

The bull case

  • Short squeeze setup with a measured path to $4.40

The bear case

  • Backdrop: Lean bearish (bias -25)
  • High short volume is routine in liquid names

The detail that changes the read

What I think traders are overlooking is the volume. Price can drift to a level on almost nothing, and what it does there needs real participation. Without it, a break is easy to fade.

That part doesn't show up on the chart.

The call, and the line that breaks it

If $ACRS posts a close above the recent high on rising volume and volume expands, I think $4.40 becomes the next serious test. Under $3.24, I'm wrong.

The honest objection is that short volume is not a short position. A high ratio is routine in liquid names, and sometimes the shorts are simply right.

So the plan is simple. Wait for the level, wait for the volume, and respect the line.

Kill switch

Any one of these and the thesis is over, no averaging down, no renaming it.

  • A close through $3.24.
  • Selling absorbs the buying at a key level and price loses it on volume.
  • Order flow reverses: the sweeps and blocks turn to the other side.
  • A scheduled event changes the picture before the trigger is reached.

Where I land

I lean higher, not loudly. The setup earns the lean and not the conviction, and it gets the conviction only when volume shows up.

Desk record. 40 of 253 scenario targets traded before their invalidation (16%), 144 stopped out, 69 ran out of time, average outcome +0.02% per piece. Past pieces say nothing about this one.

The desk's scenario leans bullish. Bull or bear, the kill switch above is what keeps either view honest.

Sources and further reading: SEC EDGAR filings for ACRS · FINRA daily short sale volume files · Nasdaq short interest: ACRS · Cboe options quotes: ACRS · Aclaris Therapeutics, Inc. investor site · ACRS quote, chart and data on StockMarketLoop.

Data as of Nov 16, 11:12 AM ET: options positioning, FINRA short volume, the off-exchange trade record, the structure map, SEC filings and the ticker's headlines. Vaughn McNair (Grandmaster-Obi) and Making Easy Money may hold or trade positions in the names discussed. This is speculation and education, not financial advice.

Author disclosure: educational scenario from the Academy data desk; the author may hold or trade positions in the names discussed. This is not financial advice.
Share card
Making Easy Money

Sign up now to get access to the library of members-only issues.

Free. Confirm by email. One click to leave.

Discussion (0)

Sign in to join the discussion.